Vantage Consulting Group’s Trueblue TBI Stock Holding History

Vantage Consulting Group’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-406	Closed	-$8K	–	1400
2020 Q4	$8K	Buy	+406	New	+$7.3K	﹤0.01%	1333

Other funds holding TBI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Vantage Consulting Group's TBI Position: Q1 2021 in Review

Vantage Consulting Group sold out of Trueblue (TBI) in Q1 2021, closing a stake of 406 shares — an estimated $8K sold.

Vantage Consulting Group first reported a position in TBI in Q4 2020 and held it in 1 quarter. The position peaked at $8K in Q4 2020. 153 funds tracked by Wall St. Rank hold TBI as of Q1 2021.

Vantage Consulting Group reported no remaining Trueblue position as of Q1 2021 after selling out during the quarter.
Vantage Consulting Group sold 406 Trueblue shares in Q1 2021, an estimated $8K.
Vantage Consulting Group first reported a position in Trueblue in Q4 2020 and held it in 1 quarter.
Vantage Consulting Group's Trueblue position peaked at $8K in Q4 2020.
153 funds tracked by Wall St. Rank held Trueblue as of Q1 2021.

Based on Vantage Consulting Group's 13F filing for Q1 2021, filed 14 May 2021.